Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial

Chronic hepatitis B (CHB) remains a major worldwide public health concern. Besifovir dipivoxil maleate (BSV) is a new promising treatment for CHB. However, long-term efficacy and safety have not yet been evaluated. Therefore, the goal of the study is to determine the antiviral efficacy and safety of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Gastroenterol
Hauptverfasser: Yim, Hyung Joon, Kim, Won, Ahn, Sang Hoon, Yang, Jin Mo, Jang, Jae Young, Kweon, Yong Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, Jung, Young Kul, Um, Soon Ho, Sohn, Joo Hyun, Lee, Jin Woo, Park, Sung Jae, Lee, Byung Seok, Kim, Ju Hyun, Kim, Hong Soo, Yoon, Seung Kew, Kim, Moon Young, Lee, Kwan Sik, Lim, Young Suk, Lee, Wan Sik, Han, Kwang-Hyub
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402376/
https://ncbi.nlm.nih.gov/pubmed/32355123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000605
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge